Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02073773Phase 3Completed
Phase 3, randomised, single-blind trial in ischemic stroke (2 arms), sponsored by Singapore General Hospital. Primary endpoint: Fugl Meyer Upper Limb score at 2 weeks. Started Jan 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02073773.